Literature DB >> 2154358

Cerebellar ataxia and hypogonadism. A clinicopathological report.

G De Michele1, A Filla, F P D'Armiento, S Striano, F Barbieri, G Salvatore, V Di Carlo, D Mansi.   

Abstract

A female showed primary amenorrhea and slowly progressive ataxia of limbs and gait, that had started when she was 18 years old. Endocrine data were consistent with hypogonadotropic hypogonadism. She died at 35 years of age. Post mortem examination showed mucinous carcinoma of the lung, hypoplastic uterus, atrophic ovaries. The cerebellum was small, with the atrophy most marked in the vermis, and the pons was shrinked. There was almost complete Purkinje cell disappearance and neuronal loss in the granular layer and the inferior olives.

Entities:  

Mesh:

Year:  1990        PMID: 2154358     DOI: 10.1016/0303-8467(90)90010-3

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  3 in total

1.  Ataxia, dementia, and hypogonadotropism caused by disordered ubiquitination.

Authors:  David H Margolin; Maria Kousi; Yee-Ming Chan; Elaine T Lim; Jeremy D Schmahmann; Marios Hadjivassiliou; Janet E Hall; Ibrahim Adam; Andrew Dwyer; Lacey Plummer; Stephanie V Aldrin; Julia O'Rourke; Andrew Kirby; Kasper Lage; Aubrey Milunsky; Jeff M Milunsky; Jennifer Chan; E Tessa Hedley-Whyte; Mark J Daly; Nicholas Katsanis; Stephanie B Seminara
Journal:  N Engl J Med       Date:  2013-05-08       Impact factor: 91.245

2.  Multiple pituitary hormone deficiencies in a patient with spinocerebellar ataxia: magnetic resonance imaging and hormonal studies.

Authors:  E Bhatia; R Shukla; R K Gupta; U K Misra
Journal:  J Endocrinol Invest       Date:  1993-09       Impact factor: 4.256

3.  Early-onset cerebellar ataxia, myoclonus and hypogonadism in a case of mitochondrial complex III deficiency treated with vitamins K3 and C.

Authors:  A Toscano; M C Fazio; G Vita; S Cannavó; N Bresolin; L Bet; A Prelle; B Barbiroli; S Iotti; P Zaniol
Journal:  J Neurol       Date:  1995-03       Impact factor: 4.849

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.